Sandbox:Maneesha: Difference between revisions
Jump to navigation
Jump to search
| Line 6: | Line 6: | ||
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Category | ! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Category | ||
! colspan="2" rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases | ! colspan="2" rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases | ||
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Benign or Malignant | |||
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Benign | ! colspan="8" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Clinical manifestation | ||
! colspan=" | |||
! colspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Paraclinical findings | ! colspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Paraclinical findings | ||
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard diagnosis | ! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard diagnosis | ||
| Line 16: | Line 14: | ||
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demography | ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demography | ||
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |History | ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |History | ||
! colspan=" | ! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Symptoms | ||
! colspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Signs | ! colspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Signs | ||
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab findings | ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab findings | ||
| Line 22: | Line 20: | ||
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging | ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging | ||
|- | |- | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Pain | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Pain | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Dysphagia | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Dysphagia | ||
| Line 32: | Line 29: | ||
! rowspan="10" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Congenital | ! rowspan="10" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Congenital | ||
! colspan="2" align="center" style="background:#DCDCDC;" |Branchial cleft cyst | ! colspan="2" align="center" style="background:#DCDCDC;" |Branchial cleft cyst | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" |Benign | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 51: | Line 45: | ||
|- | |- | ||
! colspan="2" align="center" style="background:#DCDCDC;" |Thyroglossal duct cyst | ! colspan="2" align="center" style="background:#DCDCDC;" |Thyroglossal duct cyst | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 70: | Line 61: | ||
|- | |- | ||
! colspan="2" align="center" style="background:#DCDCDC;" |Hemangioma | ! colspan="2" align="center" style="background:#DCDCDC;" |Hemangioma | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 89: | Line 77: | ||
|- | |- | ||
! colspan="2" align="center" style="background:#DCDCDC;" |Vascular malformations | ! colspan="2" align="center" style="background:#DCDCDC;" |Vascular malformations | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 108: | Line 93: | ||
|- | |- | ||
! colspan="2" align="center" style="background:#DCDCDC;" |Lymphatic malformations | ! colspan="2" align="center" style="background:#DCDCDC;" |Lymphatic malformations | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 127: | Line 109: | ||
|- | |- | ||
! colspan="2" align="center" style="background:#DCDCDC;" |Laryngocele | ! colspan="2" align="center" style="background:#DCDCDC;" |Laryngocele | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 146: | Line 125: | ||
|- | |- | ||
! colspan="2" align="center" style="background:#DCDCDC;" |Ranula | ! colspan="2" align="center" style="background:#DCDCDC;" |Ranula | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 165: | Line 141: | ||
|- | |- | ||
! colspan="2" align="center" style="background:#DCDCDC;" |Teratoma | ! colspan="2" align="center" style="background:#DCDCDC;" |Teratoma | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 184: | Line 157: | ||
|- | |- | ||
! colspan="2" align="center" style="background:#DCDCDC;" |Dermoid cyst | ! colspan="2" align="center" style="background:#DCDCDC;" |Dermoid cyst | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 203: | Line 173: | ||
|- | |- | ||
! colspan="2" align="center" style="background:#DCDCDC;" |Thymic cyst | ! colspan="2" align="center" style="background:#DCDCDC;" |Thymic cyst | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 223: | Line 190: | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Category | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Category | ||
! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases | ! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Benign | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Benign | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demography | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demography | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |History | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |History | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Pain | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Pain | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Dysphagia | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Dysphagia | ||
| Line 243: | Line 207: | ||
| rowspan="21" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Inflammatory | | rowspan="21" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Inflammatory | ||
! colspan="2" align="center" style="background:#DCDCDC;" |Acute sialadenitis | ! colspan="2" align="center" style="background:#DCDCDC;" |Acute sialadenitis | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 262: | Line 223: | ||
|- | |- | ||
! colspan="2" align="center" style="background:#DCDCDC;" |Chronic sialadenitis | ! colspan="2" align="center" style="background:#DCDCDC;" |Chronic sialadenitis | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 282: | Line 240: | ||
! rowspan="4" align="center" style="background:#DCDCDC;" |Reactive viral lymphadenopathy | ! rowspan="4" align="center" style="background:#DCDCDC;" |Reactive viral lymphadenopathy | ||
! align="center" style="background:#DCDCDC;" |CMV | ! align="center" style="background:#DCDCDC;" |CMV | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 301: | Line 256: | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |EBV | ! align="center" style="background:#DCDCDC;" |EBV | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 320: | Line 272: | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |HIV | ! align="center" style="background:#DCDCDC;" |HIV | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 339: | Line 288: | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |Viral URI | ! align="center" style="background:#DCDCDC;" |Viral URI | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 359: | Line 305: | ||
! rowspan="6" align="center" style="background:#DCDCDC;" |Bacterial lymphadenopathy | ! rowspan="6" align="center" style="background:#DCDCDC;" |Bacterial lymphadenopathy | ||
! align="center" style="background:#DCDCDC;" |Tularemia | ! align="center" style="background:#DCDCDC;" |Tularemia | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 378: | Line 321: | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |Brucellosis | ! align="center" style="background:#DCDCDC;" |Brucellosis | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 397: | Line 337: | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |Cat-scratch disease | ! align="center" style="background:#DCDCDC;" |Cat-scratch disease | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 417: | Line 353: | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |Actinomycosis | ! align="center" style="background:#DCDCDC;" |Actinomycosis | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 436: | Line 369: | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |Mycobacterial infections | ! align="center" style="background:#DCDCDC;" |Mycobacterial infections | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 455: | Line 385: | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |Staphylococcal or streptococcal infection | ! align="center" style="background:#DCDCDC;" |Staphylococcal or streptococcal infection | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 475: | Line 402: | ||
! align="center" style="background:#DCDCDC;" |Parasitic lymphadenopathy | ! align="center" style="background:#DCDCDC;" |Parasitic lymphadenopathy | ||
! align="center" style="background:#DCDCDC;" |Toxoplasma gondii | ! align="center" style="background:#DCDCDC;" |Toxoplasma gondii | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 494: | Line 418: | ||
|- | |- | ||
! colspan="2" align="center" style="background:#DCDCDC;" |Sarcoidosis | ! colspan="2" align="center" style="background:#DCDCDC;" |Sarcoidosis | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 513: | Line 434: | ||
|- | |- | ||
! colspan="2" align="center" style="background:#DCDCDC;" |Amyloidosis | ! colspan="2" align="center" style="background:#DCDCDC;" |Amyloidosis | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 532: | Line 450: | ||
|- | |- | ||
! colspan="2" align="center" style="background:#DCDCDC;" |Sjögren syndrome | ! colspan="2" align="center" style="background:#DCDCDC;" |Sjögren syndrome | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 551: | Line 466: | ||
|- | |- | ||
! colspan="2" align="center" style="background:#DCDCDC;" |Castleman disease (angiofollicular lymphoproliferative disease) | ! colspan="2" align="center" style="background:#DCDCDC;" |Castleman disease (angiofollicular lymphoproliferative disease) | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 570: | Line 482: | ||
|- | |- | ||
! colspan="2" align="center" style="background:#DCDCDC;" |Kikuchi disease (histiocytic necrotizing lymphadenitis) | ! colspan="2" align="center" style="background:#DCDCDC;" |Kikuchi disease (histiocytic necrotizing lymphadenitis) | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 589: | Line 498: | ||
|- | |- | ||
! colspan="2" align="center" style="background:#DCDCDC;" |Kimura disease | ! colspan="2" align="center" style="background:#DCDCDC;" |Kimura disease | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 608: | Line 514: | ||
|- | |- | ||
! colspan="2" align="center" style="background:#DCDCDC;" |Rosai-Dorfman disease | ! colspan="2" align="center" style="background:#DCDCDC;" |Rosai-Dorfman disease | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 627: | Line 530: | ||
|- | |- | ||
! colspan="2" align="center" style="background:#DCDCDC;" |Kawasaki disease | ! colspan="2" align="center" style="background:#DCDCDC;" |Kawasaki disease | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 647: | Line 547: | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Category | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Category | ||
! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases | ! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Benign | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Benign | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demography | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demography | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |History | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |History | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Pain | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Pain | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Dysphagia | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Dysphagia | ||
| Line 667: | Line 564: | ||
! rowspan="20" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Neoplasm | ! rowspan="20" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Neoplasm | ||
! colspan="2" align="center" style="background:#DCDCDC;" |Primary thyroid tumor | ! colspan="2" align="center" style="background:#DCDCDC;" |Primary thyroid tumor | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 687: | Line 581: | ||
! rowspan="10" align="center" style="background:#DCDCDC;" |Salivary gland neoplasm | ! rowspan="10" align="center" style="background:#DCDCDC;" |Salivary gland neoplasm | ||
! align="center" style="background:#DCDCDC;" |Pleomorphic adenoma | ! align="center" style="background:#DCDCDC;" |Pleomorphic adenoma | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 706: | Line 597: | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |Warthin's tumor | ! align="center" style="background:#DCDCDC;" |Warthin's tumor | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 725: | Line 613: | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |Lymphoepithelioma | ! align="center" style="background:#DCDCDC;" |Lymphoepithelioma | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 744: | Line 629: | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |Oncocytoma | ! align="center" style="background:#DCDCDC;" |Oncocytoma | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 763: | Line 645: | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |Monomorphic adenoma | ! align="center" style="background:#DCDCDC;" |Monomorphic adenoma | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 782: | Line 661: | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |Mucoepidermoid carcinoma | ! align="center" style="background:#DCDCDC;" |Mucoepidermoid carcinoma | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 801: | Line 677: | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |Adenoid cystic carcinoma | ! align="center" style="background:#DCDCDC;" |Adenoid cystic carcinoma | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 820: | Line 693: | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |Adenocarcinoma | ! align="center" style="background:#DCDCDC;" |Adenocarcinoma | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 839: | Line 709: | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |Salivary duct carcinoma | ! align="center" style="background:#DCDCDC;" |Salivary duct carcinoma | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 858: | Line 725: | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |Squamous cell carcinoma | ! align="center" style="background:#DCDCDC;" |Squamous cell carcinoma | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 877: | Line 741: | ||
|- | |- | ||
! colspan="2" align="center" style="background:#DCDCDC;" |Parathyroid tumors | ! colspan="2" align="center" style="background:#DCDCDC;" |Parathyroid tumors | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 896: | Line 757: | ||
|- | |- | ||
! colspan="2" align="center" style="background:#DCDCDC;" |Carotid body tumors | ! colspan="2" align="center" style="background:#DCDCDC;" |Carotid body tumors | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 915: | Line 773: | ||
|- | |- | ||
! colspan="2" align="center" style="background:#DCDCDC;" |Paraganglioma | ! colspan="2" align="center" style="background:#DCDCDC;" |Paraganglioma | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 934: | Line 789: | ||
|- | |- | ||
! colspan="2" align="center" style="background:#DCDCDC;" |Schwannoma | ! colspan="2" align="center" style="background:#DCDCDC;" |Schwannoma | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 953: | Line 805: | ||
|- | |- | ||
! colspan="2" align="center" style="background:#DCDCDC;" |Lymphoma | ! colspan="2" align="center" style="background:#DCDCDC;" |Lymphoma | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 972: | Line 821: | ||
|- | |- | ||
! colspan="2" align="center" style="background:#DCDCDC;" |Liposarcoma | ! colspan="2" align="center" style="background:#DCDCDC;" |Liposarcoma | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 991: | Line 837: | ||
|- | |- | ||
! colspan="2" align="center" style="background:#DCDCDC;" |Lipoma | ! colspan="2" align="center" style="background:#DCDCDC;" |Lipoma | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 1,010: | Line 853: | ||
|- | |- | ||
! colspan="2" align="center" style="background:#DCDCDC;" |Glomus vagale, glomus jugulare tumors | ! colspan="2" align="center" style="background:#DCDCDC;" |Glomus vagale, glomus jugulare tumors | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 1,029: | Line 869: | ||
|- | |- | ||
! colspan="2" align="center" style="background:#DCDCDC;" |Metastatic head and neck carcinoma | ! colspan="2" align="center" style="background:#DCDCDC;" |Metastatic head and neck carcinoma | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 1,049: | Line 886: | ||
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other | ! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other | ||
! colspan="2" align="center" style="background:#DCDCDC;" |Hematoma | ! colspan="2" align="center" style="background:#DCDCDC;" |Hematoma | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 1,068: | Line 902: | ||
|- | |- | ||
! colspan="2" align="center" style="background:#DCDCDC;" |Arteriovenous fistula | ! colspan="2" align="center" style="background:#DCDCDC;" |Arteriovenous fistula | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 1,087: | Line 918: | ||
|- | |- | ||
! colspan="2" align="center" style="background:#DCDCDC;" |Goiter | ! colspan="2" align="center" style="background:#DCDCDC;" |Goiter | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| Line 1,107: | Line 935: | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Category | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Category | ||
! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases | ! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Benign | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Benign | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demography | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demography | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |History | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |History | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Pain | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Pain | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Dysphagia | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Dysphagia | ||
Revision as of 19:42, 23 January 2019
Differential diagnosis of neck masses
Differential diagnosis of neck masses include:
| Category | Diseases | Benign or Malignant | Clinical manifestation | Paraclinical findings | Gold standard diagnosis | Associated findings | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Demography | History | Symptoms | Signs | Lab findings | Histopathology | Imaging | ||||||||||
| Pain | Dysphagia | Mass exam | Skin changes | LAP | Others | |||||||||||
| Congenital | Branchial cleft cyst | Benign | ||||||||||||||
| Thyroglossal duct cyst | ||||||||||||||||
| Hemangioma | ||||||||||||||||
| Vascular malformations | ||||||||||||||||
| Lymphatic malformations | ||||||||||||||||
| Laryngocele | ||||||||||||||||
| Ranula | ||||||||||||||||
| Teratoma | ||||||||||||||||
| Dermoid cyst | ||||||||||||||||
| Thymic cyst | ||||||||||||||||
| Category | Diseases | Benign | Demography | History | Pain | Dysphagia | Mass exam | Skin changes | LAP | Others | Lab findings | Histopathology | Imaging | Gold standard diagnosis | Associated findings | |
| Inflammatory | Acute sialadenitis | |||||||||||||||
| Chronic sialadenitis | ||||||||||||||||
| Reactive viral lymphadenopathy | CMV | |||||||||||||||
| EBV | ||||||||||||||||
| HIV | ||||||||||||||||
| Viral URI | ||||||||||||||||
| Bacterial lymphadenopathy | Tularemia | |||||||||||||||
| Brucellosis | ||||||||||||||||
| Cat-scratch disease | ||||||||||||||||
| Actinomycosis | ||||||||||||||||
| Mycobacterial infections | ||||||||||||||||
| Staphylococcal or streptococcal infection | ||||||||||||||||
| Parasitic lymphadenopathy | Toxoplasma gondii | |||||||||||||||
| Sarcoidosis | ||||||||||||||||
| Amyloidosis | ||||||||||||||||
| Sjögren syndrome | ||||||||||||||||
| Castleman disease (angiofollicular lymphoproliferative disease) | ||||||||||||||||
| Kikuchi disease (histiocytic necrotizing lymphadenitis) | ||||||||||||||||
| Kimura disease | ||||||||||||||||
| Rosai-Dorfman disease | ||||||||||||||||
| Kawasaki disease | ||||||||||||||||
| Category | Diseases | Benign | Demography | History | Pain | Dysphagia | Mass exam | Skin changes | LAP | Others | Lab findings | Histopathology | Imaging | Gold standard diagnosis | Associated findings | |
| Neoplasm | Primary thyroid tumor | |||||||||||||||
| Salivary gland neoplasm | Pleomorphic adenoma | + | ||||||||||||||
| Warthin's tumor | + | |||||||||||||||
| Lymphoepithelioma | + | |||||||||||||||
| Oncocytoma | ||||||||||||||||
| Monomorphic adenoma | ||||||||||||||||
| Mucoepidermoid carcinoma | ||||||||||||||||
| Adenoid cystic carcinoma | ||||||||||||||||
| Adenocarcinoma | ||||||||||||||||
| Salivary duct carcinoma | ||||||||||||||||
| Squamous cell carcinoma | ||||||||||||||||
| Parathyroid tumors | ||||||||||||||||
| Carotid body tumors | ||||||||||||||||
| Paraganglioma | ||||||||||||||||
| Schwannoma | ||||||||||||||||
| Lymphoma | ||||||||||||||||
| Liposarcoma | ||||||||||||||||
| Lipoma | ||||||||||||||||
| Glomus vagale, glomus jugulare tumors | ||||||||||||||||
| Metastatic head and neck carcinoma | ||||||||||||||||
| Other | Hematoma | |||||||||||||||
| Arteriovenous fistula | ||||||||||||||||
| Goiter | ||||||||||||||||
| Category | Diseases | Benign | Demography | History | Pain | Dysphagia | Mass exam | Skin changes | LAP | Others | Lab findings | Histopathology | Imaging | Gold standard diagnosis | Associated findings | |